FDA Adverse Event Injury Summary report: N

REVACLEAR 400

MDR report key: 13061052 · Received December 22, 2021

Report

Report Number
3006552611-2021-00014
Event Type
Injury
Date Received
December 22, 2021
Date of Event
November 22, 2021
Report Date
February 4, 2022
Manufacturer
BAXTER HEALTHCARE CORPORATION
Product Code
KDI
UDI-DI
07332414124076
PMA / PMN Number
K130039
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
CA
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

SHOULD ADDITIONAL RELEVANT INFORMATION BECOME AVAILABLE, A SUPPLEMENTAL REPORT WILL BE SUBMITTED.

Additional Manufacturer Narrative · 0

H10: THE ACTUAL SAMPLE WAS RETURNED FOR EVALUATION. PVP AND NMP CONTENT EVALUATION TESTING WAS PERFORMED AND THE DEVICE PASSED. THE REPORTED CONDITION WAS NOT VERIFIED. A BATCH REVIEW WAS CONDUCTED AND THERE WERE NO DEVIATIONS FOUND RELATED TO THIS REPORTED CONDITION DURING THE MANUFACTURE OF THIS LOT. SHOULD ADDITIONAL RELEVANT INFORMATION BECOME AVAILABLE, A SUPPLEMENTAL REPORT WILL BE SUBMITTED.

Description of Event or Problem · 0

IT WAS REPORTED THAT SIXTEEN (16) MINUTES INTO TREATMENT WITH A REVACLEAR 400, THE PATIENT EXPERIENCED DIFFICULTY BREATHING, PRURITUS, RESTLESSNESS AND LOW BLOOD PRESSURE. TREATMENT WAS DISCONTINUED WITHOUT RETURNING THE EXTRACORPOREAL BLOOD TO THE PATIENT (NO BLOOD PRESSURE VALUES WERE REPORTED).THE PATIENT RECEIVED BENADRYL AND SOLUMEDROL FOR THE EVENTS. AT THE TIME OF THIS REPORT, THE PATIENT OUTCOME WAS NOT REPORTED. NO ADDITIONAL INFORMATION IS AVAILABLE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1965904 REVACLEAR 400 DIALYZER, HIGH PERMEABILITY WITH OR WITHOUT SEALED DIALYSATE SYSTEM KDI BAXTER HEALTHCARE CORPORATION NA C621400807 07332414124076

Patients

Seq Age Sex Outcome Treatment
1 Unknown Required Intervention NORMAL SALINE| TORAY